
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health is a leading provider of infusion and home healthcare management solutions, with a focus on post-acute care services. Despite facing headwinds in Q1/26 due to changes in insurance plans, the company's diversified service offerings and strong momentum in its acute therapy business indicate potential for growth. With its exposure to Stelara significantly reduced and expansion of its advanced practitioner capabilities, Option Care Health is well-positioned for long-term margin expansion and potential multiple expansion. These factors make Option Care Health a strong candidate for long-term outperformance in the healthcare industry.
Bears say
Option Care Health is facing a number of challenges, including slowing revenue growth and elevated SG&A costs that are impacting its earnings. These challenges are expected to continue in the short-term, and the company's guidance for the rest of 2026 is below analyst expectations, indicating a potential struggle to meet its financial targets. While the company has opportunities to improve its margins and become more efficient, there are also risks such as slowing specialty growth and increased competition that could impact its future performance.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares